Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Provention Bio Inc.

    NASDAQ: PRVB · Real-Time Price · USD
    24.98
    0.00 (0.00%)
    At close: Apr 26, 2023, 10:00 PM

    Provention Bio Statistics

    Share Statistics

    Provention Bio has 95.09M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 95.09M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 69.61M

    Failed to Deliver (FTD) Shares

    n/a
    		 3,056,559

    FTD / Avg. Volume

    n/a
    		 107.51%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -6.95 and the forward PE ratio is null. Provention Bio's PEG ratio is 0.43.

    PE Ratio

    n/a
    		 -6.95

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 61.25

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 6.48

    P/FCF Ratio

    n/a
    		 -10.36

    PEG Ratio

    n/a
    		 0.43
    Financial Ratio History

    Enterprise Valuation

    Provention Bio has an Enterprise Value (EV) of 769.69M.

    EV / Sales

    n/a
    		 59.69

    EV / EBITDA

    n/a
    		 -6.17

    EV / EBIT

    n/a
    		 -10.21

    EV / FCF

    n/a
    		 -10.1

    Financial Position

    The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.2.

    Current Ratio

    n/a
    		 1.93

    Quick Ratio

    n/a
    		 1.92

    Debt / Equity

    n/a
    		 0.2

    Debt / EBITDA

    n/a
    		 -0.19

    Debt / FCF

    n/a
    		 -0.31

    Interest Coverage

    n/a
    		 -123.59

    Financial Efficiency

    Return on Equity is -93.2% and Return on Invested Capital is -78.65%.

    Return on Equity

    n/a
    		 -93.2%

    Return on Assets

    n/a
    		 -47.95%

    Return on Invested Capital

    n/a
    		 -78.65%

    Revenue Per Employee

    n/a
    		 $74,109.2

    Profits Per Employee

    n/a
    		 $-652,672.41

    Employee Count

    n/a
    		 174

    Asset Turnover

    n/a
    		 0.05

    Inventory Turnover

    n/a
    		 0.42

    Taxes

    Income Tax

    n/a
    		 -13.39M

    Effective Tax Rate

    n/a
    		 10.55%

    Stock Price Statistics

    The stock price has increased by 0% in the last 52 weeks. The beta is 2.46, so Provention Bio's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.46

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 18.81

    200-Day Moving Average

    n/a
    		 9.94

    Relative Strength Index (RSI)

    n/a
    		 80.19

    Average Volume (20 Days)

    n/a
    		 2,842,990

    Income Statement

    In the last 12 months, Provention Bio had revenue of 12.89M and earned -113.56M in profits. Earnings per share was -1.52.

    Revenue

    n/a
    		 12.89M

    Gross Profit

    n/a
    		 12.38M

    Operating Income

    n/a
    		 -128.16M

    Net Income

    n/a
    		 -113.56M

    EBITDA

    n/a
    		 -124.69M

    EBIT

    n/a
    		 -125.92M

    Earnings Per Share (EPS)

    n/a
    		 -1.52
    Full Income Statement

    Balance Sheet

    The company has 44.04M in cash and 23.91M in debt, giving a net cash position of 20.13M.

    Cash & Cash Equivalents

    n/a
    		 44.04M

    Total Debt

    n/a
    		 23.91M

    Net Cash

    n/a
    		 20.13M

    Retained Earnings

    n/a
    		 -405.64M

    Total Assets

    n/a
    		 236.86M

    Working Capital

    n/a
    		 84.26M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -75.41M and capital expenditures -795K, giving a free cash flow of -76.2M.

    Operating Cash Flow

    n/a
    		 -75.41M

    Capital Expenditures

    n/a
    		 -795K

    Free Cash Flow

    n/a
    		 -76.2M

    FCF Per Share

    n/a
    		 -1.02
    Full Cash Flow Statement

    Margins

    Gross margin is 96.03%, with operating and profit margins of -993.88% and -880.69%.

    Gross Margin

    n/a
    		 96.03%

    Operating Margin

    n/a
    		 -993.88%

    Pretax Margin

    n/a
    		 -984.54%

    Profit Margin

    n/a
    		 -880.69%

    EBITDA Margin

    n/a
    		 -966.98%

    EBIT Margin

    n/a
    		 -993.88%

    FCF Margin

    n/a
    		 -590.95%

    Dividends & Yields

    PRVB does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -14.38%

    FCF Yield

    n/a
    		 -9.65%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for PRVB.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 7.47

    Graham Upside

    n/a
    		 -70.1%

    Scores

    Altman Z-Score

    n/a
    		 8.69

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist